Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1977 1
1978 1
1982 1
1988 3
1989 4
1990 1
1992 2
1993 7
1994 3
1996 1
1997 1
1998 1
1999 3
2000 1
2001 2
2002 1
2003 1
2004 2
2005 3
2007 1
2008 4
2009 4
2010 2
2011 4
2012 2
2013 3
2014 7
2015 7
2016 4
2017 4
2018 4
2019 3
2020 5
2021 3
2022 6
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Tolvaptan in patients with autosomal dominant polycystic kidney disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS; TEMPO 3:4 Trial Investigators. Torres VE, et al. N Engl J Med. 2012 Dec 20;367(25):2407-18. doi: 10.1056/NEJMoa1205511. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121377 Free PMC article. Clinical Trial.
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease.
Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators. Torres VE, et al. N Engl J Med. 2017 Nov 16;377(20):1930-1942. doi: 10.1056/NEJMoa1710030. Epub 2017 Nov 4. N Engl J Med. 2017. PMID: 29105594 Free article. Clinical Trial.
Cell type-specific roles of APOE4 in Alzheimer disease.
Blumenfeld J, Yip O, Kim MJ, Huang Y. Blumenfeld J, et al. Nat Rev Neurosci. 2024 Feb;25(2):91-110. doi: 10.1038/s41583-023-00776-9. Epub 2024 Jan 8. Nat Rev Neurosci. 2024. PMID: 38191720 Free PMC article. Review.
The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation.
Nelson MR, Liu P, Agrawal A, Yip O, Blumenfeld J, Traglia M, Kim MJ, Koutsodendris N, Rao A, Grone B, Hao Y, Yoon SY, Xu Q, De Leon S, Choenyi T, Thomas R, Lopera F, Quiroz YT, Arboleda-Velasquez JF, Reiman EM, Mahley RW, Huang Y. Nelson MR, et al. Among authors: blumenfeld j. Nat Neurosci. 2023 Dec;26(12):2104-2121. doi: 10.1038/s41593-023-01480-8. Epub 2023 Nov 13. Nat Neurosci. 2023. PMID: 37957317 Free PMC article.
MRI in autosomal dominant polycystic kidney disease.
Zhang W, Blumenfeld JD, Prince MR. Zhang W, et al. Among authors: blumenfeld jd. J Magn Reson Imaging. 2019 Jul;50(1):41-51. doi: 10.1002/jmri.26627. Epub 2019 Jan 13. J Magn Reson Imaging. 2019. PMID: 30637853 Review.
APOE4-promoted gliosis and degeneration in tauopathy are ameliorated by pharmacological inhibition of HMGB1 release.
Koutsodendris N, Blumenfeld J, Agrawal A, Traglia M, Yip O, Rao A, Kim MJ, Nelson MR, Wang YH, Grone B, Hao Y, Thomas R, Zilberter M, Yoon SY, Arriola P, Huang Y. Koutsodendris N, et al. Among authors: blumenfeld j. Cell Rep. 2023 Oct 31;42(10):113252. doi: 10.1016/j.celrep.2023.113252. Epub 2023 Oct 19. Cell Rep. 2023. PMID: 37863057 Free PMC article.
Renin-Angiotensin System Inhibition in Advanced CKD.
Sealey JE, Blumenfeld JD. Sealey JE, et al. Among authors: blumenfeld jd. N Engl J Med. 2023 Apr 13;388(15):1437. doi: 10.1056/NEJMc2302340. N Engl J Med. 2023. PMID: 37043661 No abstract available.
109 results